(3Z,5E,11E,13E)-(7R,8S,9S,15S,16R)-16-[(1S,2R,3S)-3-((2R,4R,5S,6R)-2,4-Dihydroxy-6-isopropyl-5-methyl-tetrahydro-pyran-2-yl)-2-hydroxy-1-methyl-butyl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-oxacyclohexadeca-3,5,11,13-tetraen-2-one (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (3Z,5E,11E,13E)-(7R,8S,9S,15S,16R)-16-[(1S,2R,3S)-3-((2R,4R,5S,6R)-2,4-Dihydroxy-6-isopropyl-5-methyl-tetrahydro-pyran-2-yl)-2-hydroxy-1-methyl-butyl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-oxacyclohexadeca-3,5,11,13-tetraen-2-one's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	(3Z,5E,11E,13E)-(7R,8S,9S,15S,16R)-16-[(1S,2R,3S)-3-((2R,4R,5S,6R)-2,4-Dihydroxy-6-isopropyl-5-methyl-tetrahydro-pyran-2-yl)-2-hydroxy-1-methyl-butyl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-oxacyclohexadeca-3,5,11,13-tetraen-2-one Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	P2X purinoceptor 3 Protein (Entity type)	IC50
	(3Z,5E,11E,13E)-(7R,8S,9S,15S,16R)-16-[(1S,2R,3S)-3-((2R,4R,5S,6R)-2,4-Dihydroxy-6-isopropyl-5-methyl-tetrahydro-pyran-2-yl)-2-hydroxy-1-methyl-butyl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-oxacyclohexadeca-3,5,11,13-tetraen-2-one Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	V-type proton ATPase subunit S1 Protein (Entity type)	IC50